Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 3dds.1

Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.80 Å
Oligo State
homo-dimer
Ligands
2 x NBG: N-acetyl-beta-D-glucopyranosylamine(Non-covalent)
1 x PO4: PHOSPHATE ION(Non-functional Binders)
2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
2 x CFF: CAFFEINE(Non-covalent)
3 x 26B: O-tert-butyl-N-[(3-{[(2,4,6-trimethylphenyl)carbamoyl]amino}naphthalen-2-yl)carbonyl]-L-threonine(Non-covalent)
1 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Thomson, S.A. et al., Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorg.Med.Chem.Lett. (2009)
Release Date
2009-01-27
Peptides
Glycogen phosphorylase, liver form: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Glycogen phosphorylase, liver form

Related Entries With Identical Sequence

3dd1.1 | 3ddw.1